Common Stock, Shares, Outstanding of Viridian Therapeutics, Inc.\DE from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Viridian Therapeutics, Inc.\DE quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Viridian Therapeutics, Inc.\DE Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 101,826,500, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Viridian Therapeutics, Inc.\DE Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 101,826,500 +20,832,454 +26% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 82,229,158 +3,047,713 +3.8% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 81,651,186 +17,771,511 +28% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 81,589,427 +17,790,891 +28% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 80,994,046 +27,007,934 +50% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 79,181,445 +35,480,456 +81% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 63,879,675 +20,317,467 +47% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 63,798,536 +20,743,218 +48% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 53,986,112 +12,680,165 +31% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 43,700,989 +3,456,634 +8.6% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 43,562,208 +15,098,228 +53% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 43,055,318 +19,131,314 +80% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 41,305,947 +17,381,943 +73% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 40,244,355 +20,867,721 +108% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 28,463,980 +19,855,094 +231% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 23,924,004 +16,692,634 +231% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 23,924,004 +19,692,869 +465% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 19,376,634 -37,697,844 -66% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 8,608,886 -44,468,462 -84% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 7,231,370 -45,845,978 -86% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 4,231,135 +1,907,009 +82% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 57,074,478 +25,892,729 +83% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 53,077,348 +22,039,985 +71% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 53,077,348 +22,156,129 +72% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 2,324,126 -28,515,337 -92% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 31,181,749 +348,382 +1.1% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 31,037,363 +441,570 +1.4% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 30,921,219 +734,679 +2.4% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 30,839,463 +8,271,457 +37% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 30,833,367 +8,946,799 +41% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 30,595,793 +9,112,253 +42% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 30,186,540 +8,784,712 +41% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 22,568,006 +21,734,262 +2607% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 21,886,568 +11,096,146 +103% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 21,483,540 +10,705,634 +99% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 21,401,828 +10,692,748 +100% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 833,744 +124,720 +18% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 10,790,422 +154,968 +1.5% 30 Sep 2016 10-Q 26 Oct 2016 2016 Q3
Q2 2016 10,777,906 +2,932,376 +37% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 10,709,080 +3,204,090 +43% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 709,024 -3,073,605 -81% 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q3 2015 10,635,454 +6,852,825 +181% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 7,845,530 +4,062,901 +107% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 7,504,990 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 3,782,629 +3,782,629 31 Dec 2014 10-K 21 Mar 2016 2015 FY
Q3 2014 3,782,629 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 3,782,629 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q4 2013 0 31 Dec 2013 10-K 27 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.